Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kawasaki Safety Service Industries is a Japanese technology company specializing in the development and manufacture of automated cell culture systems and laboratory equipment for the life sciences industry. The company is widely recognized for its "Cell-Pet" product line, which offers automated solutions for the expansion, maintenance, and observation of various cell types, including induced pluripotent stem cells (iPSCs). These systems are designed to standardize complex manual procedures, ensuring high reproducibility and reducing contamination risks in regenerative medicine and drug discovery workflows. Beyond automation, the company provides specialized CO2 incubators and biological safety cabinets that meet the rigorous standards of clinical research. By bridging the gap between manual laboratory work and industrial-scale production, Kawasaki Safety Service Industries plays a critical role in the advancement of cell-based therapies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kawasaki Safety Service Industries.